Key facts
- It has raised $6.4M; the latest was Seed Round ($520K) in Apr 2025.
- Notable investors include EIT Food, Big Idea Ventures, CPT Capital, Food Labs, FoodHack — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Bright Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Bright Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bright Biotech
Operator of a contract manufacturing and development organization intended to offer a comprehensive catalog of specialized products. The company develops plant-based, affordable recombinant proteins for research and development, therapeutic, cosmeceutical, agri-food, and industrial applications, enabling clients with sustainable, scalable, and efficient technology to help fuel research and development.
- Sector
- Healthcare
- HQ
- Manchester, United Kingdom
- Founded
- 2019
- Employees
- 10
- Website
- brightbiotech.co.uk/
- Ownership
- Privately Held (backing)
Bright Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bright Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bright Biotech in its N-PORT filings yet. We sweep new filings monthly.